CHEK2 and cancer: It has been well documented that p53 is critically associated with DNA damage response, as the DNA damage-responsive kinases such as ATM and ATR and their downstream mediators CHK1 and CHK2 phosphorylate p53 at Ser15 and Ser20 [33,34], leading to p53-dependent apoptosis in several cancers [35].